A non-hallucinogenic version of the psychedelic drug ibogaine has potential for ...
New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression | India Education,Education News India,Education News
Anon-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature.
“Psychedelics are some of the most powerful drugs we know of that affect the brain,” said David Olson, assistant professor of chemistry at UC Davis and senior author on the paper. “It’s unbelievable how little ...
New Psychedelic Drug Treats Depression Without the Trip, Says Study
Once the psychedelic compound ibogaine was extracted from the African rainforest shrub Tabernanthe iboga, the researchers used a drug-designing …
Therapy with out the journey: Scientists create hallucination-free psychedelic that would battle melancholy & PTSD
California scientists have created a non-hallucinogenic model of the psychedelic drug ibogaine which they are saying may deal with a number of ailments from melancholy, habit and psychiatric problems to PTSD.
The brand new molecule, named tabernanthalog or TBG, is an artificial analog of ibogaine, which retains all the reported therapeutic advantages with none of the uncomfortable side effects which embody hallucinations but in addition cardiac toxicity.
Anecdotal proof means that ibogaine can scale back ...
Blood cells. Lots of them.
However, ibogaine is complex to synthesize, and like many natural products, not enough of the compound can be extracted from its natural source for …